Search clinical trials for: BZA

Total 12 results

VA Office of Research and Development

Not yet recruiting

Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans (CE/BZA)

Obesity | Menopause | Prediabetes

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Breast Cancer | Risk Reduction

United States
Riley Bove, MD

Recruiting

Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis (ReWRAP)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States
German CLL Study Group

Active, not recruiting

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL (CLL2-BZAG)

Chronic Lymphoid Leukemia

Germany
Carol Fabian, MD

Active, not recruiting

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

Increased Risk for Development of Breast Cancer

United States
Tulane University Health Sciences Center

Completed

Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM) (BIM)

Obesity | Glucose Homeostasis | Postmenopausal Symptoms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution

Postmenopause
Pfizer

Completed

Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women (CE/BZA)

Healthy

United States
Pfizer

Completed

Study Evaluating Changes In Mammographic Breast Density

Osteoporosis

United States, Norway, Brazil, Netherlands
Pfizer

Terminated

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

Osteoporosis | Postmenopause

China, Taiwan, Korea, Republic of

3

Subscribe